Cargando…
Retinoids, breast cancer and NK cells.
N-(4-hydroxyphenyl) retinamide (4-HPR) is a synthetic retinoid which reduces the incidence of experimental tumours in animals and has been chosen for its weak toxicity to be tested as a chemopreventive agent in humans. The mechanism of antineoplastic action is still unknown but a possible immunoenha...
Autores principales: | Villa, M. L., Ferrario, E., Trabattoni, D., Formelli, F., De Palo, G., Magni, A., Veronesi, U., Clerici, E. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1993
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1968737/ https://www.ncbi.nlm.nih.gov/pubmed/8217599 |
Ejemplares similares
-
Reduced natural killer cell activity and IL-2 production in malnourished cancer patients.
por: Villa, M. L., et al.
Publicado: (1991) -
The Molecular Basis of Retinoids’ Use in Breast Cancer Chemoprevention
por: Karamouzis, Michalis V., et al.
Publicado: (2007) -
The breakdown of the cytokine network subsequent to human immunodeficiency virus infection
por: Clerici, M., et al.
Publicado: (1995) -
Anti-tumor effects of retinoids combined with trastuzumab or tamoxifen in breast cancer cells: induction of apoptosis by retinoid/trastuzumab combinations
por: Koay, Debbie C, et al.
Publicado: (2010) -
Retinoids in Oncology
por: Rustin, G.J.S.
Publicado: (1994)